What is MaRS EXCITE?

As part of the MaRS Health services, the MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a collaboration between a range of stakeholders in the health system that work together to help innovative health technologies get to market faster and improve patient outcomes.

At the end of the program, companies will have a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both Health Canada licensing and reimbursement and purchasing reviews.

 

EXCITE is now accepting applications

Until September 19, 2014 health technology innovators of any size can apply to the MaRS EXCITE program. The application process is very simple. Read the application guide and submit your a completed application form along with an executive summary and supporting documents to excite@marsdd.com

Apply
Beside device

  • Video: Zayna Khayat speaks on the Future of Health More...
  • openFDA releases API to Medical Device Events Data collected since early 1990s access More...
  • Funding opportunity: OGI’s Pre-commercialization Business Development Fund More...
  • Video: CADTH explains how the Common Drug Review helps Canadian healthcare decision makers More...
  • Apply now! MaRS EXCITE opens sixth call for innovative health technologies More...
  • Teresa Mattarelli joins EXCITE Management Board More...
  • Article: Limits of Cost-Effectiveness Analysis and HTA More...
  • Video: “How do we balance supply and demand of health innovations?” More...
  • EXCITE CSO Dr. Les Levin receives distinguished service award at ISPOR More...
  • THETA announces launch of SIESTA study to examine ApneaDx More...